Determine accurate body weights prior to treatment. Administer subcutaneously under the loose skin of the middle of the side of the neck per the following dosages depending on age and bodyweight of the cattle: Cattle up to 1 year, 1 mL/100 lb bodyweight Cattle from 1-2 years, 1 mL/150 lb bodyweight Cattle over 2 years, 1 mL/200 lb bodyweight To be administered as a single dose. MULTIMIN® 90 is to be given subcutan...
Store between 15°C and 30°C (59°F and 86°F). Approved by FDA under NADA # 141-582
www.axiota.com
www.fda.gov/reportanimalaewww.axiota.com/patentMULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
A sterile solution for subcutaneous injection containing 60 mg/mL zinc, 15 mg/mL copper, 10 mg/mL manganese, and 5 mg/mL selenium.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
An injectable blue aqueous sterile solution for subcutaneous injection.
Active Ingredients:
Zinc 60 mg/mL (as zinc oxide)
Copper 15 mg/mL (as copper carbonate)
Manganese 10 mg/mL (as manganese carbonate)
Selenium 5 mg/mL (as sodium selenite)
Inactive Ingredients:
Edetic acid 399.74 mg/mL
Sodium hydroxide 106.9 mg/mL
Benzyl alcohol 10.4 mg/mL (as preservative)
To provide a supplemental source of zinc, copper, manganese, and selenium in cattle. Not for use in pregnant cows and heifers during their first trimester because reproductive safety testing has not been done in these animals. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because safety has not been established.
Determine accurate body weights prior to treatment. Administer subcutaneously under the loose skin of the middle of the side of the neck per the following dosages depending on age and bodyweight of the cattle:
Cattle up to 1 year, 1 mL/100 lb bodyweight
Cattle from 1-2 years, 1 mL/150 lb bodyweight
Cattle over 2 years, 1 mL/200 lb bodyweight
To be administered as a single dose.
MULTIMIN® 90 is to be given subcutaneously (under the skin) ONLY.
The maximum volume per injection site is 7 mL. Use standard aseptic procedures during administration to reduce the risk of injection site abscesses or lesions. Ensure there are at least 4 inches between injection sites for MULTIMIN® 90 and other injection sites.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days before considering repeat dosing. Additional zinc, copper, manganese, or selenium products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If more than 15 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
Do not use MULTIMIN® 90
concurrently with other injectable selenium
and copper products.
Do not use MULTIMIN® 90 concurrently with
selenium or copper boluses.
Withdrawal Periods and Residue Warnings
Cattle must not be slaughtered for human food consumption within 14 days of the last treatment. No milk discard time is required when used according to labeling. A withdrawal period has not been established in pre-ruminating calves.
Not for use in humans. Keep out of reach of children. Do not allow children access to used or empty syringes. Wash hands after use.
This product is highly concentrated in zinc, copper, manganese, and selenium. Due to a potential risk of zinc, copper, manganese, and selenium toxicity, care should be taken when handling the product to avoid accidental self-injection. Symptoms of exposure to zinc, copper, manganese, and selenium include aches, chills, nausea, vomiting, diarrhea, tachycardia, epigastric pain, tremors, and irritability.
In case of accidental self-injection or ingestion, SEEK IMMEDIATE MEDICAL ATTENTION and take the vial with you.
To obtain a Safety Data Sheet, contact Multimin North America, Inc. at +1-877-907-5315.
Selenium and copper are toxic if administered in excess. MULTIMIN® 90 may cause clinical signs associated with copper toxicity or selenium toxicity, including death, if overdosed or used in conjunction with excessive dietary levels of copper and selenium or other selenium or copper products. Additional zinc, copper, manganese, or selenium products should not be administered at the same time. Do not use concurrently with other injectable selenium and copper products. Do not use concurrently with selenium or copper boluses.
MULTIMIN® 90 may cause injection site swelling that appears on the day of injection and resolves by 2 days later. MULTIMIN® 90 may cause induration at the injection site that appears the day of injection and may persist for at least 14 days post-injection. These reactions may result in trim loss of edible tissue at slaughter.
Do not use in cases of known hypersensitivity to the active ingredients or to any of the excipients. Do not use in emaciated cattle with a body condition score of 1 on a 5-point scale in dairy or 1-3 on a 9-point scale in beef.
Do not use during the first trimester of pregnancy because safety has not been evaluated. Do not use in pre-ruminant calves because safety has not been evaluated.
Accidental overdose of copper or selenium through misdosing or the use of multiple sources, including the use of injectable products in addition to high dietary levels, can result in adverse events, including death, depression, weakness, ataxia, salivation, and drooling.
Contact Multimin North America, Inc. at +1-877-907-5315 or www.axiota.com. To report suspected adverse drug experiences, contact Multimin North America, Inc. at +1-877-907-5315. For additional information about reporting adverse drug experiences for animal drugs, contact FDA at 1-888-FDA-VETS (1-888-332-8387) or www.fda.gov/reportanimalae
As essential minerals, zinc, copper, manganese, and selenium, contribute to homeostasis by participating as cofactors of a wide range of enzymes in multiple biochemical processes in the body. In a laboratory margin of safety study in 32 growing cattle less than 1 year of age, after daily subcutaneous administration of MULTIMIN® 90 (zinc, copper, manganese, and selenium injection) for 3 days (see Target Animal Safety section), a dose-related increase in plasma concentrations of zinc, copper, manganese, and selenium was observed for treated animals when compared with untreated controls.
MULTIMIN® 90 or saline was injected subcutaneously over 3 consecutive days to 32 English and/or Continental pure or mixed beef breed cattle (16 non-pregnant females and 16 intact males, 4 animals per sex per treatment group) ranging in weight from 289-387 kg and less than 10 months of age. Treatment groups were 1x [1 mL MULTIMIN® 90/100 lb (45 kg) body weight (BW)], 3x [3 mL MULTIMIN® 90/100 lb (45 kg) BW], 5x [5 mL MULTIMIN® 90/100 lb (45 kg) BW], or control group [5 mL saline/100 lb (45 kg) BW]. All animals were euthanized and necropsied 1 to 2 days after the last treatment. The only treatment-associated findings from the 1x dose group included injection site swelling and a minor, clinically insignificant, dose and time dependent decrease in cholesterol. The treatment-associated findings from the 3x dose group were injection site swelling, a decrease in feed consumption, and a decrease in cholesterol. In the 5x dose group, treatment-associated findings included injection site swelling, a decrease in feed consumption, a decrease in cholesterol, an increase in creatinine kinase, a decrease in calcium, and signs of acute copper toxicity (2 out of 8 animals), including sudden death, depression, weakness, ataxia, salivation, and drooling. Animals in the 5x dose group also had hepatic centrilobular necrosis on necropsy and an increase in serum chemistries associated with liver damage.
Sixteen animals were each injected with MULTIMIN® 90 and saline subcutaneously on opposite sides of the neck. Eleven animals were administered 1 mL/50 kg body weight and the other 5 animals received the maximum dose per injection site of 7 mL. Injection of MULTIMIN® 90 resulted in pain upon injection (1 of 16 animals); injection site swelling that appeared on the day of injection and resolved 2 days later; and induration that appeared on the day of injection and persisted for at least 14 days. Subcutaneous injection of MULTIMIN® 90 in cattle can cause a local tissue reaction. These reactions may result in trim loss of edible tissue at slaughter.
To provide a supplemental source of zinc, copper, manganese, and selenium was demonstrated in a single multisite study. A total of 90 Holstein replacement dairy heifers, approximately 9 months of age, were administered either a single subcutaneous injection of MULTIMIN® 90 or saline at a dose of 1 mL/100 lb (45 kg) BW on Day 0. Blood samples were obtained for plasma zinc, copper, manganese, and selenium analysis within 1 to 2 hours prior to dosing, and 0.5 hours (± 10 minutes), 1 hour (± 10 minutes), 3 hours (± 15 minutes), 6 hours (± 15 minutes), and 8 hours (± 15 minutes) post-treatment. Treatment was considered successful if the partial area under the plasma concentration curve from dosing to 8 hours (AUC0-8) of zinc, copper, manganese, and selenium was significantly different and higher in the MULTIMIN® 90 treated group versus the saline treated group. For all four minerals the AUC0-8 was different and higher in the MULTIMIN® 90 treated group versus the saline treated group. The mean AUC0-8 for zinc plasma concentration was significantly different and higher (P-value=0.0031) in the MULTIMIN® 90 treated group (16.36 hour*mg/L) compared to the saline treated group (7.74 hour*mg/L). The mean AUC0-8 for copper plasma concentration was significantly different and higher (P-value=0.0041) in the MULTIMIN® 90 treated group (8.34 hour*mg/L) compared to the saline treated group (7.05 hour*mg/L). The mean AUC0-8 for manganese plasma concentration was significantly different and higher (P-value=0.0023) in the MULTIMIN® 90 treated group (253.79 hour*μg/L) compared to the saline treated group (10.89 hour*μg/L). The mean AUC0-8 for selenium plasma concentration was significantly different and higher (P-value=0.0042) in the MULTIMIN® 90 treated group (2734.03 hour*μg/L) compared to the saline treated group (790.25 hour*μg/L).
MULTIMIN® 90 is available in the following package sizes:
100 mL vial
500 mL vial
NDC# 49920-006-01
NDC# 49920-006-05
Store between 15°C and 30°C (59°F and 86°F).
Approved by FDA under NADA # 141-582
Manufactured for: Multimin North America, Inc.,
1300 Kaw Valley Rd, Suite A, Wamego, KS 66547
U.S. Patent: www.axiota.com/patent
Made in Ireland
REVISION DATE
April 2026
MULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
A sterile solution for
subcutaneous injection
containing 60 mg/mL zinc,
15 mg/mL copper, 10 mg/mL
manganese, and
5 mg/mL selenium.
Caution: Federal law restricts
this drug to use by or on the
order of a licensed veterinarian.
Withdrawal periods and Residue Warnings
Cattle must not be slaughtered for human food
consumption within 14 days of the last treatment.
No milk discard time is required when used according to labeling.A
withdrawal period has not been established in pre-ruminating calves.
STORAGE, HANDLING, AND DISPOSAL
Store between 15ºC and 30ºC
(59ºF and 86ºF)
Manufactured for: Multimin North
America, Inc.
Wamego,KS 66547
Approved by FDA under NADA # 141-582
NET CONTENTS: 100mL
INDICATIONS FOR USE
To provide a supplemental source of
zinc, copper, manganese, and
selenium in cattle. Not for use in
pregnant cows and heifers during
their first trimester because
reproductive safety testing has not
been done in these animals. Do not
use in beef calves less than 2 months
of age, dairy calves, and veal calves
because safety has not been
established.
Before using this drug, read package
insert for full prescribing information.
Refer to inside label for dosage and
administration information.
Lot No.:
Exp. Date:
CONTRAINDICATIONS
Do not use MULTIMIN® 90 (zinc, copper,
manganese, and selenium injection) concurrently
with other injectable selenium and copper products.
Do not use MULTIMIN® 90 concurrently with
selenium or copper boluses.
User Safety Warnings
Not for use in humans. Keep out of reach of
children. Do not allow children access to used or
empty syringes. Wash hands after use.
This product is highly concentrated in zinc, copper,
manganese, and selenium. Due to a potential risk of
zinc, copper, manganese, and selenium toxicity, care
should be taken when handling the product to
avoid accidental self-injection. Symptoms of
exposure to zinc, copper, manganese, and selenium
include aches, chills, nausea, vomiting, diarrhea,
tachycardia, epigastric pain, tremors, and irritability.
In case of accidental self-injection or ingestion, SEEK
IMMEDIATE MEDICAL ATTENTION and take the vial
with you.
To obtain a Safety Data Sheet, contact Multimin
North America, Inc. at +1-877-907-5315.
Animal Safety Warnings and Precautions
Selenium and copper are toxic if administered in
excess. MULTIMIN® 90 may cause clinical signs
associated with copper toxicity or selenium toxicity,
including death, if overdosed or used in conjunction
with excessive dietary levels of copper and selenium or
other selenium or copper products. Additional zinc,
copper, manganese, or selenium products should not
be administered at the same time. Do not use
concurrently with other injectable selenium and
copper products. Do not use concurrently with
selenium or copper boluses.
MULTIMIN® 90 may cause injection site swelling that
appears on the day of injection and resolves by 2
days later. MULTIMIN® 90 may cause induration at
the injection site that appears the day of injection
and may persist for at least 14 days post-injection.
These reactions may result in trim loss of edible
tissue at slaughter.
Do not use in cases of known hypersensitivity to the
active ingredients or to any of the excipients. Do not
use in emaciated cattle with a body condition score
of 1 on a 5-point scale in dairy or 1-3 on a 9-point
scale in beef.
Do not use during the first trimester of pregnancy
because safety has not been evaluated. Do not use
in pre-ruminant calves because safety has not been
evaluated.
ACTIVE INGREDIENTS
Zinc..........................................60 mg/mL (as zinc oxide)
Copper.........................15 mg/mL (as copper carbonate)
Manganese............10 mg/mL (as manganese carbonate)
Selenium...........................5 mg/mL (as sodium selenite)
INACTIVE INGREDIENTS
Edetic acid................................................399.74 mg/mL
Sodium hydroxide......................................106.9 mg/mL
Benzyl alcohol...................10.4 mg/mL (as preservative)
DOSAGE AND ADMINISTRATION
Determine accurate body weights prior to treatment.
Administer subcutaneously under the loose skin of the
middle of the side of the neck per the following dosages
depending on age and bodyweight of the cattle:
Cattle up to 1 year, 1 mL/100 lb bodyweight
Cattle from 1-2 years, 1 mL/150 lb bodyweight
Cattle over 2 years, 1 mL/200 lb bodyweight
To be administered as a single dose.
MULTIMIN® 90 is to be
given subcutaneously
(under the skin) ONLY.
The maximum volume per injection site is 7 mL. Use standard aseptic procedures
during administration to reduce the risk of injection site abscesses or lesions. Ensure
there are at least 4 inches between injection sites for MULTIMIN® 90 and other
injection sites.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days
before considering repeat dosing. Additional zinc, copper, manganese, or selenium
products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If
more than 15 punctures are anticipated, the use of multi-dosing equipment is
recommended. When using a draw-off spike or needle with bore diameter larger than
16 gauge, discard any product remaining in the vial immediately after use.
MULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
A sterile solution for
subcutaneous injection
containing 60 mg/mL zinc,
15 mg/mL copper, 10 mg/mL
manganese, and
5 mg/mL selenium.
Caution: Federal law restricts
this drug to use by or on the
order of a licensed veterinarian.
Withdrawal periods and Residue Warnings
Cattle must not be slaughtered for human food
consumption within 14 days of the last treatment.
No milk discard time is required when used according to labeling.A
withdrawal period has not been established in pre-ruminating calves.
STORAGE, HANDLING, AND DISPOSAL
Store between 15ºC and 30ºC
(59ºF and 86ºF)
Manufactured for: Multimin North
America, Inc.
Wamego,KS 66547
Approved by FDA under NADA # 141-582
NET CONTENTS: 500mL
INDICATIONS FOR USE
To provide a supplemental source of
zinc, copper, manganese, and
selenium in cattle. Not for use in
pregnant cows and heifers during
their first trimester because
reproductive safety testing has not
been done in these animals. Do not
use in beef calves less than 2 months
of age, dairy calves, and veal calves
because safety has not been
established.
Before using this drug, read package
insert for full prescribing information.
Refer to inside label for dosage and
administration information.
Lot No.:
Exp. Date:
CONTRAINDICATIONS
Do not use MULTIMIN® 90 (zinc, copper,
manganese, and selenium injection) concurrently
with other injectable selenium and copper products.
Do not use MULTIMIN® 90 concurrently with
selenium or copper boluses.
User Safety Warnings
Not for use in humans. Keep out of reach of
children. Do not allow children access to used or
empty syringes. Wash hands after use.
This product is highly concentrated in zinc, copper,
manganese, and selenium. Due to a potential risk of
zinc, copper, manganese, and selenium toxicity, care
should be taken when handling the product to
avoid accidental self-injection. Symptoms of
exposure to zinc, copper, manganese, and selenium
include aches, chills, nausea, vomiting, diarrhea,
tachycardia, epigastric pain, tremors, and irritability.
In case of accidental self-injection or ingestion, SEEK
IMMEDIATE MEDICAL ATTENTION and take the vial
with you.
To obtain a Safety Data Sheet, contact Multimin
North America, Inc. at +1-877-907-5315.
Animal Safety Warnings and Precautions
Selenium and copper are toxic if administered in
excess. MULTIMIN® 90 may cause clinical signs
associated with copper toxicity or selenium toxicity,
including death, if overdosed or used in conjunction
with excessive dietary levels of copper and selenium or
other selenium or copper products. Additional zinc,
copper, manganese, or selenium products should not
be administered at the same time. Do not use
concurrently with other injectable selenium and
copper products. Do not use concurrently with
selenium or copper boluses.
MULTIMIN® 90 may cause injection site swelling that
appears on the day of injection and resolves by 2
days later. MULTIMIN® 90 may cause induration at
the injection site that appears the day of injection
and may persist for at least 14 days post-injection.
These reactions may result in trim loss of edible
tissue at slaughter.
Do not use in cases of known hypersensitivity to the
active ingredients or to any of the excipients. Do not
use in emaciated cattle with a body condition score
of 1 on a 5-point scale in dairy or 1-3 on a 9-point
scale in beef.
Do not use during the first trimester of pregnancy
because safety has not been evaluated. Do not use
in pre-ruminant calves because safety has not been
evaluated.
ACTIVE INGREDIENTS
Zinc..........................................60 mg/mL (as zinc oxide)
Copper.........................15 mg/mL (as copper carbonate)
Manganese............10 mg/mL (as manganese carbonate)
Selenium...........................5 mg/mL (as sodium selenite)
INACTIVE INGREDIENTS
Edetic acid................................................399.74 mg/mL
Sodium hydroxide......................................106.9 mg/mL
Benzyl alcohol...................10.4 mg/mL (as preservative)
DOSAGE AND ADMINISTRATION
Determine accurate body weights prior to treatment.
Administer subcutaneously under the loose skin of the
middle of the side of the neck per the following dosages
depending on age and bodyweight of the cattle:
Cattle up to 1 year, 1 mL/100 lb bodyweight
Cattle from 1-2 years, 1 mL/150 lb bodyweight
Cattle over 2 years, 1 mL/200 lb bodyweight
To be administered as a single dose.
MULTIMIN® 90 is to be
given subcutaneously
(under the skin) ONLY.
The maximum volume per injection site is 7 mL. Use standard aseptic procedures
during administration to reduce the risk of injection site abscesses or lesions. Ensure
there are at least 4 inches between injection sites for MULTIMIN® 90 and other
injection sites.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days
before considering repeat dosing. Additional zinc, copper, manganese, or selenium
products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If
more than 15 punctures are anticipated, the use of multi-dosing equipment is
recommended. When using a draw-off spike or needle with bore diameter larger than
16 gauge, discard any product remaining in the vial immediately after use.
MULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
Before using this drug, read package insert for full prescribing information.
Determine accurate body weights prior to treatment. Administer subcutaneously under the loose skin of the middle of the side of the neck per the following dosages depending on age and bodyweight of the cattle:
Cattle up to 1 year, 1 mL/100 lb bodyweight
Cattle from 1-2 years, 1 mL/150 lb bodyweight
Cattle over 2 years, 1 mL/200 lb bodyweight
To be administered as a single dose.
MULTIMIN® 90 is to be given subcutaneously (under the skin) ONLY.
The maximum volume per injection site is 7 mL. Use standard aseptic procedures during administration to reduce the risk of injection site abscesses or lesions. Ensure there are at least 4 inches between injection sites for MULTIMIN® 90 and other injection sites.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days before considering repeat dosing. Additional zinc, copper, manganese, or selenium products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If more than 15 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days before considering repeat dosing. Additional zinc, copper, manganese, or selenium products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If more than 15 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
STORAGE, HANDLING AND DISPOSAL
Store between 15ºC and 30ºC (59ºF and 86ºF)
CONTRAINDICATIONS
Do not use MULTIMIN® 90 (zinc, copper, manganese, and selenium injection) concurrently with other injectable selenium and copper products.
Do not use MULTIMIN® 90 concurrently with selenium or copper boluses.
User Safety Warnings
Not for use in humans. Keep out of reach of children. Do not allow children access to used or empty syringes. Wash hands after use.
This product is highly concentrated in zinc, copper, manganese, and selenium. Due to a potential risk of zinc, copper, manganese, and selenium toxicity, care should be taken when handling the product to avoid accidental self-injection. Symptoms of exposure to zinc, copper, manganese, and selenium include aches, chills, nausea, vomiting, diarrhea, tachycardia, epigastric pain, tremors, and irritability.
In case of accidental self-injection or ingestion, SEEK IMMEDIATE MEDICAL ATTENTION and take the vial with you.
To obtain a Safety Data Sheet, contact Multimin North America, Inc. at +1-877-907-5315.
Animal Safety Warnings and Precautions
Selenium and copper are toxic if administered in excess. MULTIMIN® 90 may cause clinical signs associated with copper toxicity or selenium toxicity, including death, if overdosed or used in conjunction with excessive dietary levels of copper and selenium or other selenium or copper products. Additional zinc, copper, manganese, or selenium products should not be administered at the same time. Do not use concurrently with other injectable selenium and copper products. Do not use concurrently with selenium or copper boluses.
MULTIMIN® 90 may cause injection site swelling that appears on the day of injection and resolves by 2 days later. MULTIMIN® 90 may cause induration at the injection site that appears the day of injection and may persist for at least 14 days post-injection. These reactions may result in trim loss of edible tissue at slaughter.
Do not use in cases of known hypersensitivity to the active ingredients or to any of the excipients. Do not use in emaciated cattle with a body condition score of 1 on a 5-point scale in dairy or 1-3 on a 9-point scale in beef.
Do not use during the first trimester of pregnancy because safety has not been evaluated. Do not use in pre-ruminant calves because safety has not been evaluated.
Lot No:
Exp Date:
MULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
A sterile solution for subcutaneous injection containing 60 mg/mL zinc, 15 mg/mL copper, 10 mg/mL manganese, and 5 mg/mL selenium.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Approved by FDA under NADA # 141-582
NET CONTENTS: 100 mL
INDICATIONS FOR USE
To provide a supplemental source of zinc, copper, manganese, and selenium in cattle. Not for use in pregnant cows and heifers during their first trimester because reproductive safety testing has not been done in these animals. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because safety has not been established.
ACTIVE INGREDIENTS:
Zinc 60 mg/mL (as zinc oxide)
Copper 15 mg/mL (as copper carbonate)
Manganese 10 mg/mL (as manganese carbonate)
Selenium 5 mg/mL (as sodium selenite)
INACTIVE INGREDIENTS:
Edetic acid 399.74 mg/mL
Sodium hydroxide 106.9 mg/mL
Benzyl alcohol 10.4 mg/mL (as preservative)
Withdrawal Periods and Residue Warnings
Cattle must not be slaughtered for human food consumption within 14 days of the last treatment. No milk discard time is required when used according to labeling. A withdrawal period has not been established in pre-ruminating calves.
MANUFACTURED FOR:MULTIMIN NORTH AMERICA,INC.
1300 Kaw Valley Rd, Suite A,
Wamego,KS 66547
U.S. Patent: www.axiota.com/patent
Made in Ireland
NDC#49920-006-01
MULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
Before using this drug, read package insert for full prescribing information.
Determine accurate body weights prior to treatment. Administer subcutaneously under the loose skin of the middle of the side of the neck per the following dosages depending on age and bodyweight of the cattle:
Cattle up to 1 year, 1 mL/100 lb bodyweight
Cattle from 1-2 years, 1 mL/150 lb bodyweight
Cattle over 2 years, 1 mL/200 lb bodyweight
To be administered as a single dose.
MULTIMIN® 90 is to be given subcutaneously (under the skin) ONLY.
The maximum volume per injection site is 7 mL. Use standard aseptic procedures during administration to reduce the risk of injection site abscesses or lesions. Ensure there are at least 4 inches between injection sites for MULTIMIN® 90 and other injection sites.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days before considering repeat dosing. Additional zinc, copper, manganese, or selenium products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If more than 15 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
MULTIMIN® 90 is intended as a single dose product. Allow a minimum of 30 days before considering repeat dosing. Additional zinc, copper, manganese, or selenium products should not be administered at the same time.
Use within 28 days of first puncture of the vial and puncture a maximum of 15 times. If more than 15 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
STORAGE, HANDLING AND DISPOSAL
Store between 15ºC and 30ºC (59ºF and 86ºF)
CONTRAINDICATIONS
Do not use MULTIMIN® 90 (zinc, copper, manganese, and selenium injection) concurrently with other injectable selenium and copper products.
Do not use MULTIMIN® 90 concurrently with selenium or copper boluses.
User Safety Warnings
Not for use in humans. Keep out of reach of children. Do not allow children access to used or empty syringes. Wash hands after use.
This product is highly concentrated in zinc, copper, manganese, and selenium. Due to a potential risk of zinc, copper, manganese, and selenium toxicity, care should be taken when handling the product to avoid accidental self-injection. Symptoms of exposure to zinc, copper, manganese, and selenium include aches, chills, nausea, vomiting, diarrhea, tachycardia, epigastric pain, tremors, and irritability.
In case of accidental self-injection or ingestion, SEEK IMMEDIATE MEDICAL ATTENTION and take the vial with you.
To obtain a Safety Data Sheet, contact Multimin North America, Inc. at +1-877-907-5315.
Animal Safety Warnings and Precautions
Selenium and copper are toxic if administered in excess. MULTIMIN® 90 may cause clinical signs associated with copper toxicity or selenium toxicity, including death, if overdosed or used in conjunction with excessive dietary levels of copper and selenium or other selenium or copper products. Additional zinc, copper, manganese, or selenium products should not be administered at the same time. Do not use concurrently with other injectable selenium and copper products. Do not use concurrently with selenium or copper boluses.
MULTIMIN® 90 may cause injection site swelling that appears on the day of injection and resolves by 2 days later. MULTIMIN® 90 may cause induration at the injection site that appears the day of injection and may persist for at least 14 days post-injection. These reactions may result in trim loss of edible tissue at slaughter.
Do not use in cases of known hypersensitivity to the active ingredients or to any of the excipients. Do not use in emaciated cattle with a body condition score of 1 on a 5-point scale in dairy or 1-3 on a 9-point scale in beef.
Do not use during the first trimester of pregnancy because safety has not been evaluated. Do not use in pre-ruminant calves because safety has not been evaluated.
Lot No:
Exp Date:
MULTIMIN® 90
(zinc, copper, manganese, and selenium injection)
A sterile solution for subcutaneous injection containing 60 mg/mL zinc, 15 mg/mL copper, 10 mg/mL manganese, and 5 mg/mL selenium.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Approved by FDA under NADA # 141-582
NET CONTENTS: 500 mL
INDICATIONS FOR USE
To provide a supplemental source of zinc, copper, manganese, and selenium in cattle. Not for use in pregnant cows and heifers during their first trimester because reproductive safety testing has not been done in these animals. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because safety has not been established.
ACTIVE INGREDIENTS:
Zinc 60 mg/mL (as zinc oxide)
Copper 15 mg/mL (as copper carbonate)
Manganese 10 mg/mL (as manganese carbonate)
Selenium 5 mg/mL (as sodium selenite)
INACTIVE INGREDIENTS:
Edetic acid 399.74 mg/mL
Sodium hydroxide 106.9 mg/mL
Benzyl alcohol 10.4 mg/mL (as preservative)
Withdrawal Periods and Residue Warnings
Cattle must not be slaughtered for human food consumption within 14 days of the last treatment. No milk discard time is required when used according to labeling. A withdrawal period has not been established in pre-ruminating calves.
MANUFACTURED FOR:MULTIMIN NORTH AMERICA,INC.
1300 Kaw Valley Rd, Suite A,
Wamego,KS 66547
U.S. Patent: www.axiota.com/patent
Made in Ireland
NDC#49920-006-01
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0840202269078 | GTIN-13: 0840202269078 EAN-13: 0840202269078 GTIN-12: 840202269078 UPC-A: 840202269078 GTIN storage (14 digits): 00840202269078 | US MM90 500ml Carton.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 86fffa7b-d382-4771-a253-25cccb64b590 | Product name | 3 | 20251124 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CUPRIC CARBONATE | ACTIVE INGREDIENT | 9AOA5F11GJ | 3 | |
| MANGANESE CARBONATE | ACTIVE INGREDIENT | 9ZV57512ZM | 3 | |
| SODIUM SELENITE | ACTIVE INGREDIENT | HIW548RQ3W | 3 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 3 | |
| CUPRIC CATION | ACTIVE MOIETY | 8CBV67279L | 3 | |
| MANGANESE CATION (2+) | ACTIVE MOIETY | H6EP7W5457 | 3 | |
| SELENITE ION | ACTIVE MOIETY | KXO0259XJ1 | 3 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 3 | |
| CHLOROCRESOL | INACTIVE INGREDIENT | 36W53O7109 | 3 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49920-006 | 49920-006-01, 49920-006-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
| MANGANESE CARBONATE | 9ZV57512ZM | ACTIM |
| SODIUM SELENITE | HIW548RQ3W | ACTIR |
| CUPRIC CARBONATE | 9AOA5F11GJ | ACTIM |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| WATER | 059QF0KO0R | IACT |
| EDETIC ACID | 9G34HU7RV0 | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 18 | 2025-11-05 | full-release | 2026-06-01 02:46:15 |
| 15 | 2024-09-12 | full-release | 2026-06-01 02:43:29 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | OINTMENT / TOPICAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ELIXIR / ORAL | 1.3 mg/5ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAMUSCULAR | 10 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TRANSDERMAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / NASAL | 0.1 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRA-ARTICULAR | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / AURICULAR (OTIC) | 0.1 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ENEMA / RECTAL | 60 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RESPIRATORY (INHALATION) | 43 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SUBCUTANEOUS | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / OPHTHALMIC | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TOPICAL | 24 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / ORAL | 432 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INFILTRATION | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CAPSULE / ORAL | 5 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / OPHTHALMIC | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.